CDEK by Data4ThePeople

Sign in Sign up

← All drugs Report issue

cd19/baff-r

Cell therapyexperimental

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1

0

Phase 2

0

Phase 3

0

Phase 4

0

Mechanism of action

Tumor necrosis factor receptor superfamily member 13CImmunity, passive
TNFRSF13C immunity, passive
- Tumor necrosis factor receptor superfamily member 13C (TNFRSF13C) ↗
B-lymphocyte antigen CD19Immunity, passive
CD19 immunity, passive
- B-lymphocyte antigen CD19 (CD19) ↗

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No